Temporal Indication of Marijuana Use Can Be Estimated From Plasma and Urine Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, and 11-Nor-Δ9-Tetrahydrocannabinol-9-Carboxylic Acid
Current technology establishes marijuana use based upon detection of the pharmacologically inactive cannabinoid metabolite (11-nor-Δ9-carboxy-tetrahydrocannabinol-9-carboxylic acid, THC-COOH) in urine. No accurate prediction of time of use is possible because THC-COOH has a half-life of 6 days. To d...
Saved in:
Published in: | Journal of analytical toxicology Vol. 25; no. 7; pp. 538 - 549 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford University Press
01-10-2001
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Current technology establishes marijuana use based upon detection of the pharmacologically inactive cannabinoid metabolite (11-nor-Δ9-carboxy-tetrahydrocannabinol-9-carboxylic acid, THC-COOH) in urine. No accurate prediction of time of use is possible because THC-COOH has a half-life of 6 days. To determine if a temporal relationship between marijuana use and metabolite excretion patterns could be established, eight healthy user-volunteers (18–35 years old) smoked marijuana cigarettes containing 0% (placebo), 1.77%, and 3.58% Δ9-tetrahydrocannabinol (THC). Plasma and urine were collected prior to smoking, 5 min after smoking, and hourly thereafter for 8 h for measurement of cannabinoid concentrations by gas chromatography-mass spectrometry. Mathematical models proposed for determination of recent marijuana use were applied to data from this study and verified the temporal use of marijuana. One subject, who later admitted chronic marijuana use (urine baseline THCCOOH, 529.2 ng/mL; plasma, 75.5 ng/mL), excreted 8β- dibydroxy-THC, peaking 2 h postsmoking (92.3 ng/mL). Urinary THC, the psychoactive component of marijuana, concentrations peaked 2 h after smoking and declined to assay limit of detection (LOD) (1.5 ng/mL) by 6 h. 11-Hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC) and THCCOOH were detectable for the entire 8-h testing period but continued to decrease. Urinary concentrations of THC greater than 1.5 ng/mL suggests marijuana use during the previous 8-h time period. |
---|---|
AbstractList | Current technology establishes marijuana use based upon detection of the pharmacologically inactive cannabinoid metabolite (11-nor-Δ9-carboxy-tetrahydrocannabinol-9-carboxylic acid, THC-COOH) in urine. No accurate prediction of time of use is possible because THC-COOH has a half-life of 6 days. To determine if a temporal relationship between marijuana use and metabolite excretion patterns could be established, eight healthy user-volunteers (18-35 years old) smoked marijuana cigarettes containing 0% (placebo), 1.77%, and 3.58% Δ9-tetrahydrocannabinol (THC). Plasma and urine were collected prior to smoking, 5 min after smoking, and hourly thereafter for 8 h for measurement of cannabinoid concentrations by gas chromatography-mass spectrometry. Mathematical models proposed for determination of recent marijuana use were applied to data from this study and verified the temporal use of marijuana. One subject, who later admitted chronic marijuana use (urine baseline THCCOOH, 529.2 ng/mL; plasma, 75.5 ng/mL), excreted 8β- dibydroxy-THC, peaking 2 h postsmoking (92.3 ng/mL). Urinary THC, the psychoactive component of marijuana, concentrations peaked 2 h after smoking and declined to assay limit of detection (LOD) (1.5 ng/mL) by 6 h. 11-Hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC) and THCCOOH were detectable for the entire 8-h testing period but continued to decrease. Urinary concentrations of THC greater than 1.5 ng/mL suggests marijuana use during the previous 8-h time period. |
Author | Manno, Joseph E. Hagaman, Frances N. Manno, Barbara R. McWilliams, Mary E. Abukhalaf, Imad K. Kemp, Philip M. Alford, Dempsey D. Fitzgerald, Mary Jo |
Author_xml | – sequence: 1 givenname: Joseph E. surname: Manno fullname: Manno, Joseph E. organization: Department of Emergency Medicine (Section of Toxicology), Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130 – sequence: 2 givenname: Barbara R. surname: Manno fullname: Manno, Barbara R. organization: Department of Psychiatry, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130 – sequence: 3 givenname: Philip M. surname: Kemp fullname: Kemp, Philip M. organization: Chief Medical Examiner's Office, Oklahoma City, Oklahoma 73117 – sequence: 4 givenname: Dempsey D. surname: Alford fullname: Alford, Dempsey D. organization: Department of Emergency Medicine (Section of Toxicology), Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130 – sequence: 5 givenname: Imad K. surname: Abukhalaf fullname: Abukhalaf, Imad K. organization: Department of Psychiatry, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130 – sequence: 6 givenname: Mary E. surname: McWilliams fullname: McWilliams, Mary E. organization: Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130 – sequence: 7 givenname: Frances N. surname: Hagaman fullname: Hagaman, Frances N. organization: Department of Psychiatry, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130 – sequence: 8 givenname: Mary Jo surname: Fitzgerald fullname: Fitzgerald, Mary Jo organization: Department of Psychiatry, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130 |
BookMark | eNp1kctKAzEYhYMoWC87HyA7N6YmzSQzs9Ta2uKtSAXpJvwzSTF1mpTMFNr38Llc-ERmrLhzdeDw8S3OOUL7zjuD0BmjXUZzfrmA5rInumlX8GwPdVieCNJLKN9HHcoSSZJU0kN0VNcLSpnMJO-gr6lZrnyACo-dtiU01jvs5_gBgl2swQF-qQ3ug8PXBg_qxi6hMRoPg1_iSQX1EjA4jV-CdRHzrjSuCT-WutV8fuRkamLzttXBl-AcFNb56gIzRkZtt9mS_6FWHcFHH_6FSE76EIroqWyJr0qrT9DBHKranP7mMZoOB9P-iNw_3Y77V_fEpjQjItM8oSIrihJkorXkJU-l1nnscmHmGYei0LnOSlGwyIqkzbRHhZxnglJ-jM53Wr9eqVWIw4StYlS1T6j4hOoJlar4RCTJjrR1YzZ_LIR3JVOeCjV6nanR8IY_08mdmvFvbpuR9A |
ContentType | Journal Article |
Copyright | 2001 |
Copyright_xml | – notice: 2001 |
DBID | BSCLL |
DOI | 10.1093/jat/25.7.538 |
DatabaseName | Istex |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1945-2403 |
EndPage | 549 |
ExternalDocumentID | 10.1093/jat/25.7.538 ark_67375_HXZ_HFD3R0PK_Z |
GroupedDBID | --- .2P .GJ .I3 .ZR 0R~ 186 1KJ 1TH 29J 4.4 48X 53G 5GY 5VS 5WD A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAKDD AAMDB AAMVS AAOGV AAPGJ AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABEJV ABEUO ABIXL ABJNI ABKDP ABMNT ABNHQ ABNKS ABOCM ABPTD ABQLI ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACIPV ACUFI ACUTJ ACUTO ACZBC ADBBV ADEYI ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFGWE AFIYH AFOFC AFXEN AFYAG AGINJ AGKRT AGMDO AGQXC AGSYK AHXPO AI. AIAGR AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG AVNTJ AVWKF AXUDD AYOIW AZFZN BAYMD BCRHZ BEYMZ BHONS BQDIO BSCLL BSWAC BTRTY BVRKM BZKNY C45 CDBKE CXTWN DAKXR DFGAJ DILTD DU5 D~K EBD EBS EE~ EIHJH EJD ELUNK EMOBN ESTFP F3I F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HH5 HVGLF HW0 HZ~ J21 KBUDW KOP KQ8 KSI KSN M49 MBLQV MBTAY NGC NLBLG NOMLY NOYVH NU- NVLIB O0~ O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PB- PEELM Q1. Q5Y RHF ROX ROZ RUSNO RW1 RXO SV3 TCN TEORI TJX TLC TMA TN5 VH1 YAE YAYTL YKOAZ YXANX ZE2 ZGI ZXP AASNB |
ID | FETCH-LOGICAL-i708-58d34058bbca64dd63c376dd905895ef83abbd9d8c5b18d3545b1872056f85003 |
ISSN | 0146-4760 |
IngestDate | Wed Aug 28 03:23:47 EDT 2024 Wed Oct 30 09:51:26 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-i708-58d34058bbca64dd63c376dd905895ef83abbd9d8c5b18d3545b1872056f85003 |
Notes | Author to whom correspondence should be addressed: Joseph E. Manno, Ph.D., LSU Health Sciences Center, Department of Emergency of Medicine (Section of Toxicology), P.O. Box 33932, Shreveport, LA 71130-3932. ark:/67375/HXZ-HFD3R0PK-Z istex:A007A572698DE30A6B87490746B121F8786D4CFC Current address: Morehouse School of Medicine, Department of Pharmacology and Toxicology, Atlanta, GA. |
PageCount | 12 |
ParticipantIDs | oup_primary_10_1093_jat_25_7_538 istex_primary_ark_67375_HXZ_HFD3R0PK_Z |
PublicationCentury | 2000 |
PublicationDate | 2001-10 20011000 |
PublicationDateYYYYMMDD | 2001-10-01 |
PublicationDate_xml | – month: 10 year: 2001 text: 2001-10 |
PublicationDecade | 2000 |
PublicationTitle | Journal of analytical toxicology |
PublicationTitleAbbrev | Journal of Analytical Toxicology |
PublicationTitleAlternate | Journal of Analytical Toxicology |
PublicationYear | 2001 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
SSID | ssj0016863 |
Score | 1.6140933 |
Snippet | Current technology establishes marijuana use based upon detection of the pharmacologically inactive cannabinoid metabolite... |
SourceID | oup istex |
SourceType | Publisher |
StartPage | 538 |
Title | Temporal Indication of Marijuana Use Can Be Estimated From Plasma and Urine Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, and 11-Nor-Δ9-Tetrahydrocannabinol-9-Carboxylic Acid |
URI | https://api.istex.fr/ark:/67375/HXZ-HFD3R0PK-Z/fulltext.pdf |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbtswECXi5FKgKLqi6QYeml5UKtZO3epFhoGiQZA6gZGLQIkU4rSRAy-A8x_9rh76RZ0xZdpC6qQ99CIJ1IiGMY8czpBvhpD3PIz8wmkKloF2mZ_HMeOhw1kR-nnm-jx3FcYh-1-joyHvJn6y0_i08vpN23_VNLSBrpE5-w_aNp1CAzyDzuEKWofr3-ld55rCDBqyisfpYy6T0eVclMI6nSqrA6O6rawExjesWGHN2UOWyTGspK-WHC3rFEmBSAfUhzfNcbmDTnIQ-zEbKGi9uJFg_kRZCnCvdaUux2F9bF3csPtE8WdA_Gg8uVOUxawjJhn0iOm4W_moVll0Yz0tML2KjszPxotRXtsvwFrQ4_WOh5XYt95UOy_Wib02QlfX66CT9cW8aH03lAAQmcK02rVr4RPHHMSb3UXLrEVcQ-ZHuuiBrbSViP0At6W8TTOi-dvVcIk2bEKg09dUy4tAZ2i9Zbl0Vq9LMUOKTmBHtvmslg18m2iD7Lkw1cJMv9dqD8_OzE5ayHU1wdXfqMgf0Mch9HC4-h58M5xWFprnubHEGjwmjypd0pYG9ROyo8qn5KEOLFPNl3tGfq0ATtcAp-OCGoBTADgFgNO2ogbgFAFONcApII8uAU7rAMdufv74Mww_0g1obxfCritQbxOqAZoioJ-TQS8ZdPqsKkzCRlETiYrSAz-HZ1kuQl_K0MvBTEsZY4nOQBXcE1kmY8nzIHNAFpwUuEcu-BoFD8CMviC75bhULwkFZ8uRYexlOfr1yJN3ikI5vhA8j5Tv7JMPS7Wk1zr3TCom3_AoZhSk_eF52u91vZPm8ef0fJ9Q0JsR00dLvBRUnLpBGqWg4lf3i7wmD9Zj5A3ZnU3m6i1pTOX8XYWr3_YG2sY |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Oxford University Press |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Temporal+Indication+of+Marijuana+Use+Can+Be+Estimated+From+Plasma+and+Urine+Concentrations+of+%CE%949-Tetrahydrocannabinol%2C+11-Hydroxy-%CE%949-Tetrahydrocannabinol%2C+and+11-Nor-%CE%949-Tetrahydrocannabinol-9-Carboxylic+Acid&rft.jtitle=Journal+of+analytical+toxicology&rft.au=Manno%2C+Joseph+E.&rft.au=Manno%2C+Barbara+R.&rft.au=Kemp%2C+Philip+M.&rft.au=Alford%2C+Dempsey+D.&rft.date=2001-10-01&rft.pub=Oxford+University+Press&rft.issn=0146-4760&rft.eissn=1945-2403&rft.volume=25&rft.issue=7&rft.spage=538&rft.epage=549&rft_id=info:doi/10.1093%2Fjat%2F25.7.538&rft.externalDocID=10.1093%2Fjat%2F25.7.538 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-4760&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-4760&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-4760&client=summon |